News

Vir Biotechnology

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

NEWS ARTICLES

Lawmaker Plans Push For Flu Preparedness Bill Amid Brutal Season

Year-End Bill Would Require CDC Chief To Be Confirmed By The Senate

Coalition to Stop Flu Chairman Former Sen. Tom Daschle Quoted in Endpoints News

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”

The New York Times: “Flu Season Is Coming. Here’s How to Prepare.”

The Hill: “Nation warned to brace for a difficult flu season”

News

Vir Biotechnology

NEWS ARTICLES

Lawmaker Plans Push For Flu Preparedness Bill Amid Brutal Season

Year-End Bill Would Require CDC Chief To Be Confirmed By The Senate

Coalition to Stop Flu Chairman Former Sen. Tom Daschle Quoted in Endpoints News

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”

The New York Times: “Flu Season Is Coming. Here’s How to Prepare.”

The Hill: “Nation warned to brace for a difficult flu season”

Coalition Antitrust Policy

© 2023 Coalition to Stop Flu. All Rights Reserved.